An Official Website of the United States Government
IMPROVED MRI CONTRAST AGENTS
- Small Business Information
-
Woman-Owned: NoMinority-Owned: NoHUBZone-Owned: No
- Phase 1
-
Fiscal Year: 2002Title: IMPROVED MRI CONTRAST AGENTSAgency: HHSContract: 1R43CA094495-01Award Amount: $185,313.00
Abstract:
A new class of MRI contrast agents has been discovered and synthesized by Nanoprobes. Initial MRI animal studies showed excellent definition of some types of brain tumors, which were undetectable with the commonly used agent, gadodiamide. Furthermore, initial toxicity studies showed the agents to be non-toxic. One new agent was coupled to antibodies and showed high delivery to antigen on bench tests, indicating hope for development of targeted contrast agents for functional MRI. This project will focus on continued development including chemical synthesis, purification, chemical and magnetic characterization, in vivo animal studies, and antibody targeting of the agents in vivo.Small Business Information at Submission:NANOPROBES, INC.
NANOPROBES, INC. 95 HORSEBLOCK RD YAPHANK, NY 11980EIN/Tax ID: 113038451DUNS: N/ANumber of Employees: N/AWoman-Owned: NoMinority-Owned: NoHUBZone-Owned: No
Award Information
|
Agency: Department of Health and Human Services |
Branch: N/A |
Award ID: 59895 |
Program Year/Program: 2002 / SBIR |
|
Agency Tracking Number: CA094495 |
Solicitation Year: N/A |
Solicitation Topic Code: N/A |
Solicitation Number: N/A |